MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Metrics as of 10/15/2026, 07:27 AM (Berlin time), refresh in progress.

Sotera Health Company Stock

Sotera Health Company

SHCNASDAQBeobachtung
US$17.89
-1.0% today

Company data

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
United States
CEO
Alton E. Shader
Employees
3,000
Market cap
$5.1 B
IPO
20/11/2020

Sotera Health Company, headquartered in Broadview Heights, operates within the Healthcare sector. The company delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. Its sterilization capabilities encompass…

Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.

Sotera Health Company stock: price history

16/10/25+9.6 %16/10/26

1D

-1.0%

1W

-0.9%

1M

-7.4%

6M

+9.8%

YTD

+1.4%

1Y

+9.6%

2Y

+12.4%

5Y

-31.6%

10Y

–

Next earnings date

Next earnings date

03/11/2026 (in 17 days)

Volatility around earnings

~9% stronger price swings than usual

Sotera Health Company stock scores

  • Valuation

    Visible after free registration

  • Trend

    Visible after free registration

  • Quality

    Visible after free registration

  • Dividend

    Visible after free registration

  • Growth

    Visible after free registration

  • Insider

    Visible after free registration

  • Earnings

    Visible after free registration

  • Revisions

    Visible after free registration

  • Sentiment

    Visible after free registration

  • Short Pressure

    Visible after free registration

Register for free

Unlock all 11 scores

  • 5 credits free on registration
  • Access to virtual portfolios and watchlist
  • No credit card, no payment details needed
  • No subscription, no minimum term
  • Our own servers in Germany, no US cloud
Create account →

Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.

Business model & megatrends

Business model

Robust business model that benefits noticeably from at least one megatrend.

Why this value? Details with Pro only.

2 more assignments (Enabler/Second row) Pro-only.

Sotera Health Company provides specialized services in the fields of sterilization, laboratory testing, and consulting. The portfolio encompasses procedures such as gamma irradiation, electron beam, and ethylene oxide processing, as well as microbiological analyses through the Nelson Labs division. Revenue is generated primarily through services, with a smaller contribution from physical products. The addressed industries include, among others, medical devices, pharmaceuticals, as well as the food and agricultural sectors.

Revenue model
Transactional
Recurring revenue
High
Pricing power
Moderate
Moat
Narrow
Moat type
Regulatory
Capital intensity
High
Customer concentration
Unknown

Ask the agents about Sotera Health Company

Analyst assessment of Sotera Health Company

PRICE TARGET LOW

US$19.00

CONSENSUS

US$21.33

MEDIAN

US$20.00

PRICE TARGET HIGH

US$25.00

0

STRONG BUY

11

BUY

0

HOLD

1

SELL

0

STRONG SELL

12

TOTAL · Buy

As of: 14/10/2026

ANALYST FIRMRATINGACTIONDATE
JP MorganNeutral → Underweightdowngrade14/10/2026
BarclaysOverweightmaintain07/08/2026
Piper SandlerOverweightmaintain07/08/2026
JP MorganNeutralmaintain07/08/2026
CitigroupBuymaintain07/08/2026
BarclaysOverweightmaintain24/06/2026
Goldman SachsBuymaintain05/06/2026
Piper SandlerOverweightmaintain06/05/2026

Sotera Health Company stock metrics

P/E

31.21

P/B

7.68

EV/EBITDA

13.17

RETURN ON EQUITY

8.1%

NET MARGIN

16.7%

DEBT/EQUITY

3.41

DIVIDEND YIELD

0.0%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

54.1%

FLOAT SHARES

154,135,655

AVG. DAILY VOLUME (30D)

1,969,438

Insider transactions (SEC)

ROLETRANSACTIONSHARESPRICEPLAN TYPEDATE

Petras Michael B. Jr.

OfficerSale850,00018.5Spontaneous19/08/2026

Petras Michael B. Jr.

OfficerSale294,51518.5Spontaneous19/08/2026

Rutz Michael P

OfficerSale150,00018.84Spontaneous11/08/2026

Lyons Jonathan M.

OfficerTax settlement11,31617.98Spontaneous07/08/2026

Neary James

DirectorGrant14,970–Spontaneous27/05/2026
Page 1 / 4

Institutional holders

FUND / INSTITUTIONSHARESCHANGEAS OF
Two Seas Capital LP6,111,053+275,00030/09/2026
O'Keefe Stevens Advisory, Inc.838,114+37,71830/09/2026
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC225,596+78,82030/09/2026
VisionPoint Advisory Group, LLC31,667-12,86630/09/2026
State of Alaska, Department of Revenue27,035-14,60330/09/2026
Page 1 / 3

Comparable stocks

Frequently asked questions about Sotera Health Company stock

What does Sotera Health Company do?

Sotera Health Company is a company in the Healthcare sector, Medical - Diagnostics & Research industry, headquartered in United States.

The CEO is Alton E. Shader, the company employs around 3,000 people.

The IPO was on 20/11/2020; the stock trades on NASDAQ under the ticker SHC.

What do analysts say about Sotera Health Company stock?

12 analysts rate the stock, the consensus is Buy (as of 14/10/2026).

The average price target is US$21.33, ranging from US$19.00 to US$25.00, with a median of US$20.00.

This is an external assessment, not a statement by Market Jury.

When does Sotera Health Company report next?

The next earnings date is 03/11/2026.

Around past earnings, price swings were roughly 9% stronger than usual.

Does Sotera Health Company pay a dividend?

No, Sotera Health Company currently does not pay a dividend.

Which stocks are comparable to Sotera Health Company?

Comparable stocks include Thermo Fisher Scientific, Danaher, Natera, Agilent Technologies, IQVIA Holdings, Waters, Illumina and IDEXX Laboratories.

How can I get Sotera Health Company stock analyzed?

Clicking "Analyze stock" lets five strategies assess Sotera Health Company against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.